CD19-directed allogeneic memory T-cell therapy

· St. Jude Children's Research Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-directed allogeneic memory T-cell therapy, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia [Phase 1]